嵌合抗原受体自然杀伤（CAR-NK）细胞治疗乳腺癌的疗效与安全性评价：系统综述与荟萃分析
Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 4
把在研试验和前沿论文合在一起看，按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和（导航里的「临床试验」板块只收在招的那部分，不另计入）。
乳腺癌免疫治疗：从检查点抑制到新兴细胞治疗
Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies.
嵌合抗原受体 NK 细胞用于乳腺癌免疫治疗
Chimeric antigen receptor NK cells for breast cancer immunotherapy.
源自诱导多能干细胞的间皮素靶向 CAR-NK 细胞在多种临床前模型中高效杀伤三阴性乳腺癌细胞
Mesothelin-targeted CAR-NK Cells Derived From Induced Pluripotent Stem Cells Have a High Efficacy in Killing Triple-negative Breast Cancer Cells as Sh
共 4 条